Loading company…
NZeno develops genetically modified pigs for potential human kidney transplantation.
NZeno develops genetically modified pigs whose kidneys are intended for human transplantation. Its work uses gene editing to modify pigs and address immune rejection. The company is based in New Zealand and focuses on biotechnology and organ transplantation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in